IMB-XH1

Overview

IMB-XH1 is an inhibitor of myeloid cell factor 1 ( Mcl-1 ). IMB-XH1 is a non-competitive Delhi metallo-β-lactamase ( NDM-1 ) inhibitor. The IC 50 s of IMB-XH1 against metallo-β-lactamases NDM-1, IMP-4, ImiS and L1 are 0.4637 μM, 3.980 μM, 0.2287 μM and 1.158 μM, respectively.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Beta-lactamase | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-12826
• CAS No.: 292057-76-2
• Molecular Formula: C19H15N3OS
• Molecular Weight: 333.41
• Purity: 98.0%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.08 mg/mL (6.24 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source